November 23, 2021 at 12:45 pm

MISSD’s Latest Podcast Chats with Bob Fiddaman About Akathisia, SSRI Withdrawal, and Clinical Trials

More than 15 years ago when Bob Fiddaman tried to discontinue GSK’s drug, Seroxat, he suffered severe withdrawal problems and akathisia. At that time, there was little information available about these adverse effects. Bob started The Fiddaman Blog in 2006 and published a book in 2011 so that other healthcare consumers might be better informed and avoid the prescribed harms he sustained.

Listen to our interview in this latest episode of Akathisia Stories at